Related Experiment Video
Updated: Jan 13, 2026
08:40
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
18.0K
MicroRNA-Induced Regulation of the IGF-1 System in Various Types of Cancer
George Triantafyllou1, Mary Kategianni2, Maria Maridaki3
1Department of Anatomy, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Genes
|October 29, 2025
Summary
MicroRNAs (miRNAs) regulate the Insulin-like Growth Factor 1 (IGF-1) system, impacting cancer development and progression. These miRNAs show potential as cancer biomarkers and therapeutic targets for metastasis and staging.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Insulin-like Growth Factor 1 (IGF-1) is a key regulator of cellular functions via the IGF-1 receptor (IGF-1R) and IGF-binding proteins (IGFBPs).
- The IGF-1 system influences critical cancer processes including growth, survival, transformation, and invasion.
- MicroRNAs (miRNAs) regulate IGF-1 synthesis, playing a role in tumor development and progression across various cancers.
Purpose of the Study:
- To review and characterize miRNA-induced regulation of the IGF-1 system in diverse cancer types.
- To identify potential roles of miRNAs as biomarkers and therapeutic agents in cancer.
- To explore the implications of miRNA-IGF-1 interactions in cancer staging and metastasis.
Main Methods:
- Literature review and analysis of existing studies on miRNA regulation of the IGF-1 system in cancer.
- Identification of specific miRNAs targeting components of the IGF-1 bioregulation system.
- Characterization of the role of these miRNAs in different cancer types and stages.
Main Results:
- Numerous miRNAs have been identified that regulate the IGF-1 system in various cancers.
- Certain miRNAs show potential as diagnostic biomarkers for cancer.
- Other miRNAs are implicated in regulating metastasis and cancer progression by targeting IGF-1 system components.
Conclusions:
- miRNAs are significant regulators of the IGF-1 system in cancer biology.
- miRNAs targeting the IGF-1 system can serve as potential biomarkers and therapeutic targets.
- Further research is necessary to fully elucidate the role of miRNAs and their targets in cancer pathogenesis and treatment.
More Related Videos
09:45An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
8.9K
09:06MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method
Published on: October 7, 2025
335
Related Concept Videos
01:22MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
01:22MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
02:15Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
01:15Receptor Downregulation in MVBs
2.8K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.8K
02:38Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K